Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118389) titled 'Observations and Efficacy Analysis of Different Treatment Modalities for Unresectable Locally Advanced Esophageal Cancer in the Immunotherapy Era: A Real-World, Multicenter, Retrospective Study' on Feb. 4.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Fourth Hospital of Hebei Medical University
Condition:
Esophageal Carcinoma
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-02-10
Target Sample Size: Observation group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=308114...